BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26339303)

  • 1. End-of-Life Care Interventions: An Economic Analysis.
    Pham B; Krahn M
    Ont Health Technol Assess Ser; 2014; 14(18):1-70. PubMed ID: 26339303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing chronic disease management mega-analysis: economic evaluation.
    Path-Theta Collaboration
    Ont Health Technol Assess Ser; 2013; 13(13):1-148. PubMed ID: 24228076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Societal costs of home and hospital end-of-life care for palliative care patients in Ontario, Canada.
    Yu M; Guerriere DN; Coyte PC
    Health Soc Care Community; 2015 Nov; 23(6):605-18. PubMed ID: 25443659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a transitional home-based palliative care program for patients with end-stage heart failure.
    Wong FKY; So C; Ng AYM; Lam PT; Ng JSC; Ng NHY; Chau J; Sham MMK
    Palliat Med; 2018 Feb; 32(2):476-484. PubMed ID: 28434275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Care Planning Discussions for Patients at the End of Life: An Evidence-Based Analysis.
    Baidoobonso S
    Ont Health Technol Assess Ser; 2014; 14(19):1-72. PubMed ID: 26357528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada.
    Tanuseputro P; Wodchis WP; Fowler R; Walker P; Bai YQ; Bronskill SE; Manuel D
    PLoS One; 2015; 10(3):e0121759. PubMed ID: 25811195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
    Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
    Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003.
    Walker H; Anderson M; Farahati F; Howell D; Librach SL; Husain A; Sussman J; Viola R; Sutradhar R; Barbera L
    J Palliat Care; 2011; 27(2):79-88. PubMed ID: 21805942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of formal and informal care in the last year of life for patients in receipt of specialist palliative care.
    Brick A; Smith S; Normand C; O'Hara S; Droog E; Tyrrell E; Cunningham N; Johnston B
    Palliat Med; 2017 Apr; 31(4):356-368. PubMed ID: 28094677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dying to pay: the cost of end-of-life care.
    Chochinov HM; Kristjanson L
    J Palliat Care; 1998; 14(4):5-15. PubMed ID: 9893392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence on the cost and cost-effectiveness of palliative care: a literature review.
    Smith S; Brick A; O'Hara S; Normand C
    Palliat Med; 2014 Feb; 28(2):130-50. PubMed ID: 23838378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness study of person-centered integrated heart failure and palliative home care: Based on a randomized controlled trial.
    Sahlen KG; Boman K; Brännström M
    Palliat Med; 2016 Mar; 30(3):296-302. PubMed ID: 26603186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer.
    Lowery WJ; Lowery AW; Barnett JC; Lopez-Acevedo M; Lee PS; Secord AA; Havrilesky L
    Gynecol Oncol; 2013 Sep; 130(3):426-30. PubMed ID: 23769759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial.
    Halling CMB; Wolf RT; Sjøgren P; Von Der Maase H; Timm H; Johansen C; Kjellberg J
    BMC Palliat Care; 2020 Sep; 19(1):142. PubMed ID: 32933489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource utilization and cost analyses of home-based palliative care service provision: the Niagara West End-of-Life Shared-Care Project.
    Klinger CA; Howell D; Marshall D; Zakus D; Brazil K; Deber RB
    Palliat Med; 2013 Feb; 27(2):115-22. PubMed ID: 22249926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Investment in End-of-Life Home Care to Enable Death in Community Settings.
    Isenberg SR; Tanuseputro P; Spruin S; Seow H; Goldman R; Thavorn K; Hsu AT
    Med Care; 2020 Aug; 58(8):665-673. PubMed ID: 32520768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is home-based palliative care cost-effective? An economic evaluation of the Palliative Care Extended Packages at Home (PEACH) pilot.
    McCaffrey N; Agar M; Harlum J; Karnon J; Currow D; Eckermann S
    BMJ Support Palliat Care; 2013 Dec; 3(4):431-5. PubMed ID: 24950523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses.
    Davis MP; Temel JS; Balboni T; Glare P
    Ann Palliat Med; 2015 Jul; 4(3):99-121. PubMed ID: 26231807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.